Search - tctmd.com

Displaying 121 - 140 of 336

Sort: Relevancy | Date

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Shelley Wood

April 12, 2023

News Daily News

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

Caitlin E. Cox

March 28, 2023

News Daily News

Sugar Substitute Erythritol Linked to Cardiac Risk

Yael L. Maxwell

March 15, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Caitlin E. Cox

March 10, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

News Daily News

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Yael L. Maxwell

February 21, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

Todd Neale

November 06, 2022

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Advertisement

May 2023 News Roundup

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

Sugar Substitute Erythritol Linked to Cardiac Risk

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

TCTMD’s Top 10 Most Popular Stories for February 2023

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Only Half of Revascularized PAD Patients Receive GDMT

December 2022 News Roundup

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

SCAD in Men: Canadian Study Sheds Light on Rare Condition

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content